glp-1 nafld and Glucagon Receptor Dual Agonists in the Management of Metabolic Dysfunction-associated Steatotic Disease (MASLD) | Current Hepatology Reports Multiple target tissue effects of

A compendium of ruminant gastrointestinal phage genomes revealed a higher proportion of lytic phages than in any other environments

Bariatric surgeryif you and your surgeon agree it is appropriateis another option for those with severe obesity seeking durable weight loss before pregnancy

Ozempic is part of a class of drugs known as glucagon peptide-1, or GLP-1, receptor agonists

Metabolic Health: Improves overall metabolic markers including insulin sensitivity and lipid profiles

While no strict diet is required, a balanced, nutrient-rich diet will enhance the effectiveness of the treatment and promote long-term success